MASTIVET ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ
MASTIVET ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ
Authorised
- Trueperella pyogenes, strain ATCC 9730, Inactivated
- Escherichia coli (inactivated)
- Staphylococcus aureus, Inactivated
- STREPTOCOCCUS PYOGENES INACTIVATED BACTERIA
- Streptococcus uberis, Inactivated
- Streptococcus dysgalactiae subsp. dysgalactiae, Inactivated
- Streptococcus agalactiae, Inactivated
Product identification
Medicine name:
MASTIVET ΕΝΕΣΙΜΟ ΕΝΑΙΩΡΗΜΑ
Active substance:
- Trueperella pyogenes, strain ATCC 9730, Inactivated
- Escherichia coli (inactivated)
- Staphylococcus aureus, Inactivated
- STREPTOCOCCUS PYOGENES INACTIVATED BACTERIA
- Streptococcus uberis, Inactivated
- Streptococcus dysgalactiae subsp. dysgalactiae, Inactivated
- Streptococcus agalactiae, Inactivated
Target species:
-
Cattle
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Trueperella pyogenes, strain ATCC 9730, Inactivated1000000000.00/Colony forming unit1.00millilitre(s)
-
Escherichia coli (inactivated)1800000000.00/Colony forming unit1.00millilitre(s)
-
Staphylococcus aureus, Inactivated1000000000.00/Colony forming unit1.00millilitre(s)
-
STREPTOCOCCUS PYOGENES INACTIVATED BACTERIA300000000.00/Colony forming unit1.00millilitre(s)
-
Streptococcus uberis, Inactivated300000000.00/Colony forming unit1.00millilitre(s)
-
Streptococcus dysgalactiae subsp. dysgalactiae, Inactivated300000000.00/Colony forming unit1.00millilitre(s)
-
Streptococcus agalactiae, Inactivated900000000.00/Colony forming unit1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
-
Cattle
-
Not applicableno withdrawal period
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI02AB
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Anafasis Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Laboratorios Ovejero S.A.U.
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 88483/14-12-2015/K-0185601
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet